- Financing Provided by CIT Bank Allows for Acquisition of Avalign Technologies
- Avalign Is a Premier Manufacturer in the Orthopedic Medical Device and Specialty Surgical Markets
- Represents CIT’s Third Transaction with Arlington Capital Partners
NEW YORK--(BUSINESS WIRE)--CIT Group Inc. (NYSE:CIT) cit.com, a leading provider of commercial lending and leasing services, today announced that CIT Healthcare Finance served as Joint Lead Arranger in a $135 million senior secured credit facility to support Arlington Capital Partners’ (Arlington Capital) acquisition of Avalign Technologies (Avalign). Arlington Capital is a Washington, D.C.-based private equity firm.
CIT MEDIA RELATIONS:
C. Curtis Ritter, 973-740-5390
Senior Vice President of Corporate Communications
Curt.Ritter@cit.com
or
Matt Klein, 973-597-2020
Vice President, Media Relations
Matt.Klein@cit.com
or
CIT INVESTOR RELATIONS:
Barbara Callahan, 973-740 -5058
Senior Vice President
Barbara.Callahan@cit.com